|
Volumn 10, Issue 3, 2008, Pages 187-194
|
Guidelines of the German Society for Addiction Medicine (DGS e.V.), the German AIDS Society (DAIG) and the German association of physicians in private practice treating HIV-infected persons (DAGNÄ): HIV infection in intravenous drug addicts (IVDA);Leitlinien der Deutschen Gesellschaft für Suchtmedizin (DGS e.V.), der Deutschen AIDS-Gesellschaft (DAIG) und der Deutschen Arbeitsgemeinschaft niedergelassener Ärzte (DAGNÄ): HIV-Infektion bei intravenös Drogenabhängigen (IVDA)
a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABACAVIR;
ABACAVIR PLUS LAMIVUDINE;
ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE;
AMPRENAVIR PHOSPHATE;
ATAZANAVIR;
BUPRENORPHINE;
DARUNAVIR;
DIDANOSINE;
EFAVIRENZ;
EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
EMTRICITABINE;
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
ENFUVIRTIDE;
INDINAVIR;
LAMIVUDINE;
LAMIVUDINE PLUS ZIDOVUDINE;
LOPINAVIR;
LOPINAVIR PLUS RITONAVIR;
MARAVIROC;
METHADONE;
NEVIRAPINE;
RALTEGRAVIR;
RITONAVIR;
SAQUINAVIR;
STAVUDINE;
TENOFOVIR;
TENOFOVIR DISOPROXIL;
TIPRANAVIR;
ZIDOVUDINE;
AREA UNDER THE CURVE;
COMORBIDITY;
CONFERENCE PAPER;
DRUG CLEARANCE;
DRUG DEPENDENCE;
DRUG METABOLISM;
GERMANY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INTRAVENOUS DRUG ABUSE;
MEDICAL SOCIETY;
PRACTICE GUIDELINE;
PREVALENCE;
|
EID: 53849097002
PISSN: 14375567
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (5)
|
References (0)
|